Hongbo Lu, Ph.D.
Board Member
Arrowhead Pharmaceuticals, Inc. (ARWR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hongbo Lu, Ph.D.
Hongbo Lu, Ph.D. is recorded as Board Member at Arrowhead Pharmaceuticals, Inc. (ARWR). Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed February 22, 2024 that Hongbo Lu, Ph.D. was appointed independent director, effective April 1, 2024.
“On February 21, 2024, the Board of Directors of Arrowhead Pharmaceuticals, Inc. (the "Company") announced that it would increase the size of the Company's board of directors ("Board") from seven to eight members and appoint Hongbo Lu, Ph.D., as an independent director of the Company, effective April 1, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-04-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arrowhead Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Anzalone CEO, Board Member
- Daniel Apel CFO
- Patrick O'Brien COO
- Patrick O’Brien COO, General Counsel
- Douglas Ingram Board Member
- Dr. Matt Cohen, M.D., M.B.A. Board Member
- Hongbo Lu Board Member
- Oye Olukotun, M.D., MPH Board Member
- Victoria Vakiener Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.